Symbol="MESO"
AssetType="Common Stock"
Name="Mesoblast Ltd"
Description="Mesoblast Limited, a biopharmaceutical company, develops and markets allogeneic cellular drugs. The company is headquartered in Melbourne, Australia."
CIK="1345099"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)"
Address="LEVEL 38, 55 COLLINS STREET, MELBOURNE, VICTORIA, AU"
FiscalYearEnd="June"
LatestQuarter="2023-03-31"
MarketCapitalization="210664000"
EBITDA="-67471000"
PERatio="0.131"
PEGRatio="0"
BookValue="3.275"
DividendPerShare="0"
DividendYield="0"
EPS="9.68"
RevenuePerShareTTM="0.055"
ProfitMargin="0"
OperatingMarginTTM="-9.23"
ReturnOnAssetsTTM="-0.0657"
ReturnOnEquityTTM="-0.163"
RevenueTTM="7586000"
GrossProfitTTM="-53361000"
DilutedEPSTTM="9.68"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="-0.036"
AnalystTargetPrice="8.83"
TrailingPE="0.131"
ForwardPE="833.33"
PriceToSalesRatioTTM="56.79"
PriceToBookRatio="0.93"
EVToRevenue="62.57"
EVToEBITDA="-7.87"
Beta="2.386"
num_52WeekHigh="5.12"
num_52WeekLow="1.16"
num_50DayMovingAverage="3.623"
num_200DayMovingAverage="3.379"
SharesOutstanding="162732000"
DividendDate="None"
ExDividendDate="None"
symbol="MESO"
open="1.30"
high="1.35"
low="1.24"
price="1.30"
volume="516364.00"
latest_trading_day="2023-08-16"
previous_close="1.27"
change="0.03"
change_percent="2.3622%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="47"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Sell Signal"
volume_analysis="Trending High"
value_analysis="Bullish Trend"
Aroon_change="FALSE"
Aroon_momentum="53"
Volume_recent_avg="310141"
Change_recent_avg="-0.01"
Delta_recent_avg="0.15"
Variance_recent_avg="0.07"
Change_ratio_recent_avg="-0.3"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="53"
Aroon_momentum_negative="47"
image_negative_thumbnail_id_1="1161"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0195.jpeg"
image_negative_thumbnail_id_2="97"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0079.jpeg"
image_neutral_thumbnail_id_1="544"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0055.jpeg"
image_neutral_thumbnail_id_2="586"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0013.jpeg"
image_positive_thumbnail_id_1="1002"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0164.jpeg"
image_positive_thumbnail_id_2="634"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0074.jpeg"
image_professor_thumbnail_id_1="1196"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0030.jpeg"
image_professor_thumbnail_id_2="1192"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0026.jpeg"
